|
1
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arkan MC: Cancer: Fat and the fate of
pancreatic tumours. Nature. 536:157–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Samuel N and Hudson TJ: The molecular and
cellular heterogeneity of pancreatic ductal adenocarcinoma. Nat Rev
Gastroenterol Hepatol. 9:77–87. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Birney E, Stamatoyannopoulos JA, Dutta A,
Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis
ET, Thurman RE, et al: Identification and analysis of functional
elements in 1% of the human genome by the ENCODE pilot project.
Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lander ES, Linton LM, Birren B, Nusbaum C,
Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al:
Initial sequencing and analysis of the human genome. Nature.
409:860–921. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen Z, Chen X, Chen P, Yu S, Nie F, Lu B,
Zhang T, Zhou Y, Chen Q, Wei C, et al: Long non-coding RNA SNHG20
promotes non-small cell lung cancer cell proliferation and
migration by epigenetically silencing of P21 expression. Cell Death
Dis. 8:e30922017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin J, Tan X, Qiu L, Huang L, Zhou Y, Pan
Z, Liu R, Chen S, Geng R, Wu J and Huang W: Long noncoding RNA
BC032913 as a novel therapeutic target for colorectal cancer that
suppresses metastasis by upregulating TIMP3. Mol Ther Nucleic
Acids. 8:469–481. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu Y, Nangia-Makker P, Farhana L and
Majumdar APN: A novel mechanism of lncRNA and miRNA interaction:
CCAT2 regulates miR-145 expression by suppressing its maturation
process in colon cancer cells. Mol Cancer. 16:1552017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan X, Zhang D, Wu W, Wu S, Qian J, Hao Y,
Yan F, Zhu P, Wu J, Huang G, et al: Mesenchymal stem cells promote
hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and
miR-34a. Cancer Res. 77:6704–6716. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang SZ, Xu F, Zhou T, Zhao X, McDonald JM
and Chen Y: The long non-coding RNA HOTAIR enhances pancreatic
cancer resistance to TNF-related apoptosis-inducing ligand. J Biol
Chem. 292:10390–10397. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu Z, Chen C, Zhou Q, Wang Y, Zhao Y, Zhao
X, Li W, Zheng S, Ye H, Wang L, et al: LncRNA HOTTIP modulates
cancer stem cell properties in human pancreatic cancer by
regulating HOXA9. Cancer Lett. 410:68–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu JH, Chen G, Dang YW, Li CJ and Luo DZ:
Expression and prognostic significance of lncRNA MALAT1 in
pancreatic cancer tissues. Asian Pac J Cancer Prev. 15:2971–2977.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li L, Chen H, Gao Y, Wang YW, Zhang GQ,
Pan SH, Ji L, Kong R, Wang G, Jiia YH, et al: Long noncoding RNA
MALAT1 promotes aggressive pancreatic cancer proliferation and
metastasis via the stimulation of autophagy. Mol Cancer Ther.
15:2232–2243. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhan HX, Wang Y, Li C, Xu JW, Zhou B, Zhu
JK, Han HF, Wang L, Wang YS and Hu SY: LincRNA-ROR promotes
invasion, metastasis and tumor growth in pancreatic cancer through
activating ZEB1 pathway. Cancer Lett. 374:261–271. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun J, Cheng L, Shi H, Zhang Z, Zhao H,
Wang Z and Zhou M: A potential panel of six-long non-coding RNA
signature to improve survival prediction of diffuse large-B-cell
lymphoma. Sci Rep. 6:278422016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu Y, Chen HY, Yu CY, Xu J, Wang JL, Qian
J, Zhang X and Fang JY: A long non-coding RNA signature to improve
prognosis prediction of colorectal cancer. Oncotarget. 5:2230–2242.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Chen Z, Tian L, Zhou C, He MY, Gao
Y, Wang S, Zhou F, Shi S, Feng X, et al: LncRNA profile study
reveals a three-lncRNA signature associated with the survival of
patients with oesophageal squamous cell carcinoma. Gut.
63:1700–1710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou M, Xu W, Yue X, Zhao H, Wang Z, Shi
H, Cheng L and Sun J: Relapse-related long non-coding RNA signature
to improve prognosis prediction of lung adenocarcinoma. Oncotarget.
7:29720–29738. 2016.PubMed/NCBI
|
|
21
|
Law CW, Alhamdoosh M, Su S, Smyth GK and
Ritchie ME: RNA-seq analysis is easy as 1-2-3 with limma, Glimma
and edgeR. F1000Res. 5:14082016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cuccurullo V and Mansi L: AJCC cancer
staging handbook: From the AJCC cancer staging manual (7th
edition). Eur J Nucl Med Mol Imaging. 38:408. 2011. View Article : Google Scholar
|
|
23
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Z, Chen Z, Fan R, Jiang B, Chen X,
Chen Q, Nie F, Lu K and Sun M: Over-expressed long noncoding RNA
HOXA11-AS promotes cell cycle progression and metastasis in gastric
cancer. Mol Cancer. 16:822017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dong HX, Wang R, Jin XY, Zeng J and Pan J:
LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via
inhibiting hsa-mir-22-3p. J Cell Physiol. 233:4126–4136. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gong X and Huang M: Long non-coding RNA
MEG3 promotes the proliferation of glioma cells through targeting
Wnt/β-catenin signal pathway. Cancer Gene Ther. 24:381–385. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen S, Wu DD, Sang XB, Wang LL, Zong ZH,
Sun KX, Liu BL and Zhao Y: The lncRNA HULC functions as an oncogene
by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma. Cell
Death Dis. 8:e31182017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang W, Yuan W, Song J, Wang S and Gu X:
LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer
by inhibiting hypoxia-induced autophagy through inactivation of
HIF-1α. Biochimie. 144:21–27. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang
C, Dou C, Xu M, Liu Q and Tu K: Long non-coding RNA CASC2
suppresses epithelial-mesenchymal transition of hepatocellular
carcinoma cells through CASC2/miR-367/FBXW7 axis. Mol Cancer.
16:1232017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Li Z, Liu L, Wang Q, Li S, Chen
D, Hu Z, Yu T, Ding J, Li J, et al: Long noncoding RNA TSLNC8 is a
tumor suppressor that inactivates the interleukin-6/STAT3 signaling
pathway. Hepatology. 67:171–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang W, Hong L, Xu X, Wang Q, Huang J and
Jiang L: LncRNA GAS5 suppresses the tumorigenesis of cervical
cancer by downregulating miR-196a and miR-205. Tumour Biol.
39:10104283177113152017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Shen J, Chan MT and Wu WK: TUG1: A
pivotal oncogenic long non-coding RNA of human cancers. Cell
Prolif. 49:471–475. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu L, Chen X, Zhang Y, Hu Y, Shen X and
Zhu W: Long non-coding RNA TUG1 promotes endometrial cancer
development via inhibiting miR-299 and miR-34a-5p. Oncotarget.
8:31386–31394. 2017.PubMed/NCBI
|
|
34
|
Lei H, Gao Y and Xu X: LncRNA TUG1
influences papillary thyroid cancer cell proliferation, migration
and EMT formation through targeting miR-145. Acta Biochim Biophys
Sin. 49:588–597. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kuang D, Zhang X, Hua S, Dong W and Li Z:
Long non-coding RNA TUG1 regulates ovarian cancer proliferation and
metastasis via affecting epithelial-mesenchymal transition. Exp Mol
Pathol. 101:267–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun J, Ding C, Yang Z, Liu T, Zhang X,
Zhao C and Wang J: The long non-coding RNA TUG1 indicates a poor
prognosis for colorectal cancer and promotes metastasis by
affecting epithelial-mesenchymal transition. J Transl Med.
14:422016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH,
You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long
non-coding RNA TUG1 affects cell proliferation in human non-small
cell lung cancer, partly through epigenetically regulating HOXB7
expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li J, Zhang M, An G and Ma Q: LncRNA TUG1
acts as a tumor suppressor in human glioma by promoting cell
apoptosis. Exp Biol Med. 241:644–649. 2016. View Article : Google Scholar
|
|
39
|
Durand X, Xylinas E, Radulescu C,
Haus-Cheymol R, Moutereau S, Ploussard G, Forgues A, Robert G,
Vacherot F, Loric S, et al: The value of urinary prostate cancer
gene 3 (PCA3) scores in predicting pathological features at radical
prostatectomy. BJU Int. 110:43–49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Augustin H, Mayrhofer K, Pummer K and
Mannweiler S: Relationship between prostate cancer gene 3 (PCA3)
and characteristics of tumor aggressiveness. Prostate. 73:203–210.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xie Z, Chen X, Li J, Guo Y, Li H, Pan X,
Jiang J, Liu H and Wu B: Salivary HOTAIR and PVT1 as novel
biomarkers for early pancreatic cancer. Oncotarget. 7:25408–25419.
2016.PubMed/NCBI
|
|
42
|
Peng W and Jiang A: Long noncoding RNA
CCDC26 as a potential predictor biomarker contributes to
tumorigenesis in pancreatic cancer. Biomed Pharmacother.
83:712–717. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li L, Zhang GQ, Chen H, Zhao ZJ, Chen HZ,
Liu H, Wang G, Jia YH, Pan SH, Kong R, et al: Plasma and tumor
levels of Linc-pint are diagnostic and prognostic biomarkers for
pancreatic cancer. Oncotarget. 7:71773–71781. 2016.PubMed/NCBI
|
|
44
|
Trimarchi T, Bilal E, Ntziachristos P,
Fabbri G, Dalla-Favera R, Tsirigos A and Aifantis I: Genome-wide
mapping and characterization of Notch-regulated long noncoding RNAs
in acute leukemia. Cell. 158:593–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S,
Jiang Z, Xu J, Liu Q and Cao X: The STAT3-binding long noncoding
RNA lnc-DC controls human dendritic cell differentiation. Science.
344:310–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ranzani V, Rossetti G, Panzeri I, Arrigoni
A, Bonnal RJ, Curti S, Gruarin P, Provasi E, Sugliano E, Marconi M,
et al: The long intergenic noncoding RNA landscape of human
lymphocytes highlights the regulation of T cell differentiation by
linc-MAF-4. Nat Immunol. 16:318–325. 2015. View Article : Google Scholar : PubMed/NCBI
|
